MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Validation of the new diagnostic criteria for fatigue in Parkinson’s disease

A. Mosejova, T. Merovova, I. Straka, V. Han, Z. Gdovinova, P. Valkovic, M. Skorvanek (Kosice, Slovakia)

Meeting: 2018 International Congress

Abstract Number: 1517

Keywords: Parkinsonism

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: The aim of this study was to validate the new diagnostic criteria for fatigue1 in Parkinson’s disease patients.

Background: Case definition and diagnostic criteria for fatigue in Parkinson’s disease have been published recently, nevertheless they have not been validated so far.

Methods: Sociodemographic data, diagnostic criteria for fatigue in PD and other scales including the MDS-UPDRS, Multidimensional Fatigue Inventory (MFI), Fatigue Severity Scale (FSS), Beck Depression Inventory-II (BDI-II), Apathy scale (AS) and Epsworth Sleepiness Scale (ESS) were examined in a sample of 95 consecutive patients with Parkinson’s disease. Prevalence of fatigue based on the new diagnostic criteria, FSS and MFI was evaluated. Reliability of the diagnostic criteria for fatigue was assessed using Cronbach’s alpha for internal consistency and intra-class correlation coefficients for test-retest reliability. Convergent validity with the FSS and MFI and divergent validity with the BDI-II, ESS and AS were assessed using ROC analyses.

Results: Mean age of the patient sample was 66.2 years (range 41-83), 53 patients were men, mean disease duration 7.4±5.1 years, median HY stage 2 (interquartile range 2-3). Fatigue was present in 27 patients (28.4%) based on the new diagnostic criteria, 57 patients (60%) based on the FSS and 60 patients (63.2%) based on the MFI. The new diagnostic criteria for fatigue have an excellent internal consistency with Cronbach’s alpha 0,90 and excellent test-retest reliability with intra-class coefficient 0.93 (95%CI 0.89-0.95). Convergent validity with FSS was acceptable with AUC 0.75 (95%CI 0.64-0.87) and convergent validity with MFI was ranging from AUC 0.69 (95%CI 0.57-0.81) for MFI physical fatigue to AUC 0.79 (95%CI 0.68-0.90) for MFI mental fatigue. Divergent validity with BDI-II was moderate with AUC 0.60 (95%CI 0.42-0.73), AUC for AS was 0.65 (95%CI 0.52-0.78) and AUC for ESS was 0.66 (95%CI 0.52-0.80).

Conclusions: The new diagnostic criteria for fatigue in Parkinson’s disease show good psychometric properties with excellent reliability and acceptable validity and thus can be used in future PD-related fatigue research.

References: 1. Kluger BM, Herlofson K, Chou KL, et al. Parkinson’s disease-related fatigue: a case definition and recommendations for clinical research. Mov Disord 2016; 31: 625-631.

To cite this abstract in AMA style:

A. Mosejova, T. Merovova, I. Straka, V. Han, Z. Gdovinova, P. Valkovic, M. Skorvanek. Validation of the new diagnostic criteria for fatigue in Parkinson’s disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/validation-of-the-new-diagnostic-criteria-for-fatigue-in-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/validation-of-the-new-diagnostic-criteria-for-fatigue-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley